Peregrine Capital Management’s Medidata Solutions, Inc. MDSO Stock Holding History

Peregrine Capital Management’s Portfolio MDSO Stock Details MDSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,500	Closed	-$226K	–	321
2019 Q2	$226K	Sell	2,500 -299,322	-99%	-$26.3M	0.01%	252
2019 Q1	$22.1M	Sell	301,822 -6,085	-2%	-$439K	0.55%	60
2018 Q4	$20.8M	Sell	307,907 -35,976	-10%	-$2.54M	0.59%	51
2018 Q3	$25.2M	Buy	343,883 +39,475	+13%	+$3.16M	0.6%	59
2018 Q2	$24.5M	Sell	304,408 -45,948	-13%	-$3.44M	0.61%	54
2018 Q1	$22M	Buy	350,356 +16,390	+5%	+$1.09M	0.54%	62
2017 Q4	$21.2M	Buy	333,966 +32,260	+11%	+$2.3M	0.5%	65
2017 Q3	$23.6M	Buy	301,706 +10,241	+4%	+$780K	0.57%	58
2017 Q2	$22.8M	Sell	291,465 -69,085	-19%	-$4.82M	0.57%	56
2017 Q1	$20.6M	Buy	360,550 +25,214	+8%	+$1.36M	0.52%	64
2016 Q4	$16.7M	Buy	335,336 +49,818	+17%	+$2.59M	0.43%	83
2016 Q3	$15.9M	Buy	+285,518	New	+$15.1M	0.41%	94

Other funds holding MDSO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

SCS

Syquant Capital SAS Paris, France $447M AUM 13.04% 1-Year Est. Return

Peregrine Capital Management's MDSO Position: Q3 2019 in Review

Peregrine Capital Management sold out of Medidata Solutions, Inc. (MDSO) in Q3 2019, closing a stake of 2,500 shares — an estimated $226K sold.

Peregrine Capital Management first reported a position in MDSO in Q3 2016 and held it in 12 quarters. The position peaked at $25.2M in Q3 2018. 281 funds tracked by Wall St. Rank hold MDSO as of Q3 2019.

Peregrine Capital Management reported no remaining Medidata Solutions, Inc. position as of Q3 2019 after selling out during the quarter.
Peregrine Capital Management sold 2,500 Medidata Solutions, Inc. shares in Q3 2019, an estimated $226K.
Peregrine Capital Management first reported a position in Medidata Solutions, Inc. in Q3 2016 and held it in 12 quarters.
Peregrine Capital Management's Medidata Solutions, Inc. position peaked at $25.2M in Q3 2018.
281 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q3 2019.

Based on Peregrine Capital Management's 13F filing for Q3 2019, filed 16 Oct 2019.